Atlas Venture Life Science Advisors »

Sionna Therapeutics shares owned by Atlas Venture Life Science Advisors

Quarter-by-quarter ownership of Sionna Therapeutics (SION) shares owned by Atlas Venture Life Science Advisors from 13F filings

Historical chart of Atlas Venture Life Science Advisors investment in Sionna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sionna Therapeutics held by Atlas Venture Life Science Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sionna Therapeutics by Atlas Venture Life Science Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $106M 3.6M 29.41
2025-06-30 $64M 3.7M 17.35
2025-03-31 $39M 3.7M 10.46

More positions owned by Atlas Venture Life Science Advisors

Kymera Therapeutics Common Stock (KYMR)
Disc Medicine Common Stock (IRON)
Dyne Therapeutics Common Stock (DYN)
Sionna Therapeutics Common Stock (SION)
Korro Bio Common Stock (KRRO)
Day One Biopharmaceuticals Common Stock (DAWN)
Generation Bio Common Stock
Q32 Bio Common Stock (QTTB)
ImageneBio Common Stock

View all positions for Atlas Venture Life Science Advisors

Top funds holding Sionna Therapeutics

RA Capital Management
Tpg Gp A
OrbiMed Advisors
Atlas Venture Life Science Advisors
Viking Global Investors
Enavate Sciences GP
Jpmorgan Chase & Co
Perceptive Advisors
Vanguard Group
Jennison Associates
Deerfield Management Company
Standard Life Aberdeen
BlackRock
Soleus Capital Management
Baker Bros. Advisors

View all funds holding Sionna Therapeutics